Stock Overview
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ · Healthcare · Biotechnology
Madrigal Pharmaceuticals Inc is a Healthcare company with a market capitalization of $11.82B.
Market Cap
$11.82B
Forward P/E
666.7
Price/Sales
10.4
Price/Book
21.8
EV/EBITDA
-8.3
Beta
-1.06
EPS (TTM)
$-13.48
Profit Margin
-27.3%
ROE
-49.3%
52W High
$615.00
52W Low
$284.02
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Revenue
$958.40M
Gross Profit
$902.25M
Operating Income
-$300.10M
Net Income
-$288.28M
Free Cash Flow
-$190.02M
Total Debt
$340.90M
Cash & Equivalents
$198.69M
Shareholder Equity
$602.69M
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 6, 2026 | $-1.38 | $-4.14 | +66.7% |
| Q4 2025 | February 19, 2026 | $-2.57 | $-0.60 | -325.6% |
| Q3 2025 | November 4, 2025 | $-4.96 | $-1.99 | -149.3% |
| Q2 2025 | August 5, 2025 | $-1.90 | $-3.53 | +46.2% |
| Q1 2025 | May 1, 2025 | $-3.32 | $-3.79 | +12.4% |
| Q4 2024 | February 26, 2025 | $-2.71 | $-4.12 | +34.3% |
Other Biotechnology Stocks
Frequently Asked Questions
What is Madrigal Pharmaceuticals Inc's market cap?
As of June 29, 2026, Madrigal Pharmaceuticals Inc (MDGL) has a market capitalization of $11.82B.
Does Madrigal Pharmaceuticals Inc pay a dividend?
Madrigal Pharmaceuticals Inc does not currently pay a dividend.
What sector is MDGL in?
Madrigal Pharmaceuticals Inc is in the Healthcare sector, specifically the Biotechnology industry.
What was Madrigal Pharmaceuticals Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Madrigal Pharmaceuticals Inc reported revenue of $958.40M and net income of -$288.28M.
Ask your own questions about MDGL
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.